September 29, 2016
Town Hall Center
Event website: Click here (http://www.npcnow.org/event/npcvalueconf)
Value assessment frameworks are a new and evolving field, and they have the potential to have a tremendous impact on patient treatment decisions, as well as on coverage and reimbursement decisions. These frameworks emerged in the United States in response to multiple factors, including an increased focus on patient-centered care, alternative payment models intended to incentivize health care value and public attention on new high-priced therapies.
While the current value assessment frameworks have much to teach us, initial comparisons of these frameworks highlight the important differences and analytic challenges that still remain. Continued improvements are necessary to address the different perspectives inherent in assessing value.
During the conference, the National Pharmaceutical Council (NPC) will share research that evaluates how existing frameworks align with NPC’s Guiding Practices for Patient-Centered Value Assessment and explore the variable outputs from multiple myeloma treatment assessments conducted using four different frameworks. A broad range of stakeholders will share their perspectives on the research, uncovering the lessons learned to date and how best to advance the field of value assessment.